These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6955071)

  • 1. Relationship of the duration of the chronic phase in chronic granulocytic leukaemia to the need for treatment during the first year after diagnosis.
    Wareham NJ; Johnson SA; Goldman JM
    Cancer Chemother Pharmacol; 1982; 8(2):205-10. PubMed ID: 6955071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission induction in chronic granulocytic leukaemia using intermittent high-dose busulphan.
    Douglas ID; Wiltshaw E
    Br J Haematol; 1978 Sep; 40(1):59-64. PubMed ID: 280361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between the duration of the chronic phase of chronic myeloid leukemia and total dose of busulfan in the first year of the treatment].
    Hellmann A; Koberda J; Baran W
    Acta Haematol Pol; 1990; 21(1):60-5. PubMed ID: 2260409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic granulocytic leukaemia with repeated single doses of busulphan.
    Vicariot M; Goldman JM; Catovsky D; Galton DA
    Eur J Cancer (1965); 1979 Apr; 15(4):559-63. PubMed ID: 285861
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron stores in chronic granulocytic leukaemia at presentation.
    Cervantes F; Rozman C; Brugues R; Llanas I
    Scand J Haematol; 1984 May; 32(5):469-74. PubMed ID: 6587557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-five year survival of chronic granulocytic leukaemia with spontaneous karyotype conversion.
    Singer CR; McDonald GA; Douglas AS
    Br J Haematol; 1984 Jun; 57(2):309-13. PubMed ID: 6587904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
    Sánchez Fayos J; Outeiriño J; de Villalobos E; Valera M; Alonso M; Calabuig MT; Paniagua G
    Sangre (Barc); 1981; 26(1):65-71. PubMed ID: 6942520
    [No Abstract]   [Full Text] [Related]  

  • 8. The significance of Ph1 mosaicism: a report of six cases of chronic granulocytic leukaemia and two cases of acute myeloid leukaemia.
    Wayne AW; Sharp JC; Joyner MV; Sterndale H; Pulford KA
    Br J Haematol; 1979 Nov; 43(3):353-60. PubMed ID: 291438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
    Bergsagel DE; Messner H
    Br J Cancer; 1990 Jun; 61(6):895-8. PubMed ID: 2372493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia.
    Finney R; McDonald GA; Baikie AG; Douglas AS
    Br J Haematol; 1972 Sep; 23(3):283-8. PubMed ID: 4507535
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic myeloid leukaemia in Zambians.
    Lowenthal MN
    Trop Geogr Med; 1975 Jun; 27(2):132-6. PubMed ID: 1058559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic granulocytic leukaemia. Comparison of uracil mustard and busulphan.
    Herrmann RP; Dougan L; Holt JA; Jackson JM; Matthews ML; Nelson AJ; Stenhouse NS; Woodliff HJ
    Med J Aust; 1972 Apr; 1(16):789-91. PubMed ID: 4503393
    [No Abstract]   [Full Text] [Related]  

  • 13. Econometric analysis of phase duration for blood morphology and basophil count alterations in chronic granulocytic leukaemia.
    Gola A; Smakowska E; Waszkiewicz L; Błaczkowska A; Kin-Dittmann I; Zielińska K; Czajkowska B; Pajsert E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):271-5. PubMed ID: 6205949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged survival in chronic granulocytic leukaemia after busulphan induced hypoplasia and karyotype conversion.
    Bennett M; Lewis D; Walker H
    Br J Haematol; 1985 Apr; 59(4):738-40. PubMed ID: 3857075
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytogenetic studies of the spleen in chronic granulocytic leukaemia.
    Spiers AS; Barikie AG; Bartnall JA; Cox JI
    Aust N Z J Med; 1975 Aug; 5(4):295-305. PubMed ID: 1058669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myeloid leukaemia and a myasthenic syndrome.
    Wohl MA; Wood JK
    Acta Haematol; 1979; 62(4):214-8. PubMed ID: 119414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow aplasia developing 3 years after treatment with busulphan for chronic myeloid leukaemia.
    Bowcock SJ; Galton DA; Goldman JM
    Eur J Haematol; 1989 May; 42(5):496-7. PubMed ID: 2567249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal hypertension in a patient with chronic myeloid leukaemia.
    Foadi MD; Shaw S; Paradinas FJ
    Postgrad Med J; 1977 May; 53(619):267-9. PubMed ID: 267281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil function in chronic granulocytic leukaemia before and after busulphan treatment.
    Whittaker JA; Khurshid M; Hughes HR
    Br J Haematol; 1974 Dec; 28(4):541-9. PubMed ID: 4616717
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic granulocytic leukaemia: comparison of radiotherapy and busulphan therapy. Report of the Medical Research Council's working party for therapeutic trials in leukaemia.
    Br Med J; 1968 Jan; 1(5586):201-8. PubMed ID: 5235190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.